Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies

Molecular Cancer Research

Volumn 7, Issue 8, 2009, Pages 1304-1309

  Willers, Henning ^a   Taghian, Alphonse G ^a   Luo, Chen Mei ^a   Treszezamsky, Alejandro ^a   Sgroi, Dennis C ^a   Powell, Simon N ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FANCONI ANEMIA GROUP D2 PROTEIN; PROGESTERONE RECEPTOR; RAD51 PROTEIN;

ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CLINICAL ARTICLE; DNA REPAIR; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IRRADIATION; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN FUNCTION; TUMOR BIOPSY;

BIOPSY; BRCA1 PROTEIN; BREAST; BREAST NEOPLASMS; DNA REPAIR; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; FROZEN SECTIONS; HUMANS; RAD51 RECOMBINASE; RADIATION, IONIZING; SIGNAL TRANSDUCTION;

EID: 69449090092     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0149     Document Type: Article

References (28)

1. Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003;95:1482-1485 (Pubitemid 37279334)
2. Lakhani SR, Reis-Filho JS, Fulford L, et al. Prediction of BRCA1status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005;11:5175-5180 (Pubitemid 41003703)
3. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-5374 (Pubitemid 39100473)
4. Powell SN, Kachnic LA. Roles of BRCA1and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003;22:5784-5791
5. Gudmundsdottir K, Ashworth A. The roles of BRCA1a nd BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006;25:5864-5874 (Pubitemid 44453442)
6. Powell SN, Kachnic LA. Therapeutic exploitation of tumor cell defects in homologous recombination. Anticancer Agents Med Chem 2008;8:448-460
7. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007;8:735-748 (Pubitemid 47429206)
8. Kennedy RD, D'Andrea AD. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 2006;24:3799-3808
9. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1in a common pathway. Mol Cell 2001;7:249-262 (Pubitemid 32206493)
10. Levitus M, Waisfisz Q, Godthelp BC, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 2005;37:934-935 (Pubitemid 43086148)
11. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007;39:162-164 (Pubitemid 46184345)
12. Turner N, Tutt A, Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 2004;4:814-819
13. Turner NC, Reis-Filho JS, Russell AM, et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 2007;26:2126-2132 (Pubitemid 46514749)
14. Esteller M, Silva JM, Dominguez G, et al. Promoter hypermethylation and BRCA1inac tivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000;92:564-569 (Pubitemid 30212318)
15. Staff S, Isola J, Tanner M. Haplo-insufficiency of BRCA1 in sporadic breast cancer. Cancer Res 2003;63:4978-4983 (Pubitemid 37022634)
16. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW. Methylation of the BRCA1promoter is associated with decreased BRCA1mRNA levels in clinical breast cancer specimens. Carcinogenesis 2000;21:1761-1765 (Pubitemid 30678915)
17. Essers J, Houtsmuller AB, van Veelen L, et al. Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO J 2002;21:2030-2037 (Pubitemid 34437200)
18. Lisby M, Barlow JH, Burgess RC, Rothstein R. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell 2004;118:699-713. (Pubitemid 39221730)
19. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886-895 (Pubitemid 30647617)
20. Shi W, Ma Z, Willers H, et al. Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation. J Biol Chem 2008;283:31608-31616
21. Zhang J, Willers H, Feng Z, et al. Chk2 phosphorylation of BRCA1regulates DNA double-strand break repair. Mol Cell Biol 2004;24:708-718 (Pubitemid 38057922)
22. Wang X, Andreassen PR, D'Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1in chromatin. Mol Cell Biol 2004;24:5850-5862 (Pubitemid 38787970)
23. Tarsounas M, Davies D, West SC. BRCA2-dependent and independent formation of RAD51nuclear foci. Oncogene 2003;22:1115-1123 (Pubitemid 36363377)
24. Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997;90:425-435 (Pubitemid 27347233)
25. Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK. The breast cancer susceptibility gene BRCA1is required for subnuclear assembly of Rad51and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 2000;275:23899-23903 (Pubitemid 30624678)
26. Treszezamsky AD, Kachnic LA, Feng Z, Zhang J, Tokadjian C, Powell SN. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res 2007;67:7078-7081 (Pubitemid 47206532)
27. Elkahloun AG, Gaudet J, Robinson GS, Sgroi DC. In situ gene expression analysis of cancer using laser capture microdissection, microarrays and real time quantitative PCR. Cancer Biol Ther 2002;1:354-358
28. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-5979 (Pubitemid 36576916)